Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net revenues	$ 3,676,785	$ 3,206,594
Cost of sales	2,018,883	1,957,956
Gross Profit	1,657,902	1,248,638
Operating expenses:
Research and development	541,184	615,926
Selling, general and administrative	1,086,383	1,762,026
Total operating expenses	1,627,567	2,377,952
Income (loss) from operations	30,335	(1,129,314)
Other income (expense):
Forgiveness of Payroll Protection Program	0	693,817
Interest income	13,091	3,013
Interest and finance expenses	(18,938)	(15,597)
Total other income (expense)	(5,847)	681,233
Income (loss) before provision for income taxes	24,488	(448,081)
Provision for (benefit) income taxes:
Current	(4,190)	(19,818)
Deferred	125,000	956,000
Total benefit provision for income taxes	120,810	936,182
Net loss	$ (96,322)	$ (1,384,263)
Basic and diluted per common share: (in dollars per share)	$ (0.00)	$ (0.02)
Weighted average shares of common stock outstanding - basic and diluted (in shares)	67,588,492	67,588,492